IV Disposable Market Upcoming Trends and Analysis Report 2023 to 2033

According to Future Market Insights report, the worldwide IV Disposable Market demand is estimated to develop at a CAGR of 11.8% during the forecast period. The market value is expected to rise from US$ 17.0 billion in 2023 to US$ 51.6 billion in 2033. The IV Disposable market was valued at US$ 15.5 billion by the end of 2022 and is expected to expand 9.6% year on year in 2023.

With the increasing use of infusion pumps in healthcare settings and home use, demand for items such as ventilators, infusion pumps, and accessories, which are used to treat patients, has seen a substantial demand increase. The global COVID-19 pandemic has had an unprecedented impact on the same.

IV therapies can now be used effectively and safely because to technological advancements in IV therapy products and a growing focus on cost containment and cost-effectiveness at healthcare facilities. Over the projected period, the market for Disposable IV treatment products is anticipated to rise due to patients' growing preference for safety-enhancing pumping devices and needleless technologies.

The use of Disposable products can help to reduce the risk of healthcare-associated infections, which has become a major concern for healthcare providers. This has led to a growing demand for Disposable products such as catheters, syringes, and other medical devices.

Overall, these factors are contributing to the growth of the IV Disposable market, and are expected to continue to drive demand for effective and innovative treatment options in the coming years.

Key Companies Profiled:

  • B. Braun Melsungen AG
  • Baxter
  • 3M
  • Terumo Corporation
  • Nipro Corporation
  • Teleflex Incorporated
  • Becton, Dickinson and Company
  • Smiths Medical/ICU Medical
  • Moog Inc
  • AngioDynamics.
  • Fresenius SE & Co. KgaA
  • arcomed ag

Browse Detail Summary Of Research Report@ https://www.futuremarketinsights.com/reports/iv-disposables-market

Key Segments Covered in IV Disposable Market Industry Research:

By Product:

  • Intravenous Administration Set
  • IV Fluid Solution Bags
  • IV Cannula
  • Infusion Sets
  • Infusion Pumps
  • Catheter Needles
  • Securement Devices
  • Others (Stopcocks, connectors, Extention Tubes)

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Home Care Settings

Comments

Post a Comment

Popular posts from this blog

Handheld Ultrasound Scanners Market Will Generate Booming Growth Opportunities to 2032

Image
According to industry predictions, the global Handheld Ultrasound Scanners Market Demand will increase at a CAGR of 9.1% from 2022 to 2032, reaching a value of US$ 472.1 million by the end of 2022. By 2032, sales are estimated to exceed a valuation of roughly US$ 1.1 billion. With an expected 83.6% market share in 2021, the wired modality now leads the sector. Because they connect to Bluetooth or Wi-Fi devices such as mobile phones or tablets, Handheld Ultrasound Scanners are gaining appeal among both medical professionals and non-radiologists. These devices improve networking systems and ease picture transfer to medical facilities. Global Handheld Ultrasound Scanners Market: Dynamics         Technological advancements in medical imaging devices, increased use of Handheld Ultrasound Scanners among non-radiologists, benefits from international trade agreements, increased importing of imaging diagnostics systems, increased use of Handheld Ultrasound Scanners in emergency medical service
Read more

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

Antidiabetics Market to reach US$ 223 billion by 2032, growing at a 9.6% CAGR from 2022 to 2032 | Future Market Insights, Inc.

Image
The global Antidiabetics Market is expected to earn US$ 223 billion while expanding at a CAGR of 9.6% during the forecast period. The rising prevalence of diabetes worldwide can be attributed to the market's expansion. The ageing baby boomer population is another factor driving the market during the forecast period. According to the International Diabetes Federation, the global diabetes incidence will increase from 366 million in 2011 to 552 million by 2030. During the forecast period, the industry is expected to benefit from a significant increase in the number of diabetic patients. Furthermore, new product development is expected to benefit the market in the near future. For example, Novo Nordisk, a Danish pharmaceutical company, announced the launch of oral semaglutide for the treatment of Type 2 diabetes in India in January 2022. Furthermore, the development of advanced pumps based on smart technologies like AI and ML is expected to open up a slew of new doors. For exampl
Read more